🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research project will contribute to the research surrounding the effec...
Status
Completed
Location
St Mary's Hospital
Start Date
2020-01-01
Trial ID
NCT03878875
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and effectiveness...
Status
Recruiting
Location
Medical University of South Carolina
Start Date
2025-01-07
Trial ID
NCT06737380
Treatments Being Tested
The overarching goal of this proposal is to evaluate the feasibility and ac...
Status
Completed
Location
Gugulethu Midwife Obstetric Unit
Start Date
2019-08-23
Trial ID
NCT03826199
Treatments Being Tested
Daprodustat has demonstrated an ability to effectively raise hemoglobin con...
Status
Terminated
Location
GSK Investigational Site
Start Date
2019-01-10
Trial ID
NCT03446612
This phase III trial compares the effect of adding lomustine to standard ch...
Status
Active Not Recruiting
Location
Fairbanks Memorial Hospital
Start Date
2022-03-28
Trial ID
NCT05095376
This phase II trial compares the usual treatment of radiation therapy alone...
Status
Active Not Recruiting
Location
Cancer Center at Saint Joseph's
Start Date
2022-04-20
Trial ID
NCT05053152
The investigators propose to conduct a series of N of One (No1) single blin...
Status
Withdrawn
Location
University of Texas Health Science Center
Start Date
2018-01
Trial ID
NCT02878538
Treatments Being Tested
The presence study is toComparison of Microneedling with Subepithelial Conn...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-28
Trial ID
NCT06060119
Treatments Being Tested
Safety and tolerability of three different concentrations (0.1%, 03%, 0.6%)...
Status
Completed
Location
Central Contact
Start Date
2017-05-10
Trial ID
NCT03131167
Treatments Being Tested